Maria Sklodowska-Curie National Research Institute of Oncology

🇵🇱Poland

Country: 🇵🇱Poland

Ownership: Private

Established: 1951-01-01

Employees: -

Market Cap: -

Website: https://www.pib-nio.pl/

Clinical Trials

Phase 1b/2 Study of Liposomal Annamycin (L-Annamycin) in Subjects With Previously Treated Soft-Tissue Sarcomas (STS) With Pulmonary Metastases

Phase 1

Recruiting

Conditions: Soft Tissue Sarcoma
Pulmonary Metastasis

Interventions: Drug: Liposomal Annamycin (L-Annamycin)

First Posted Date: 2022-08-26

Last Posted Date: 2022-08-26

Lead Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology

Target Recruit Count: 64

Registration Number: NCT05518526

Locations: 🇵🇱
Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Mazovian, Poland

Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines

Phase 3

Recruiting

Conditions: Cardiotoxicity

Interventions: Drug: Empagliflozin 10 MG
Other: Placebo

First Posted Date: 2022-03-08

Last Posted Date: 2024-11-27

Lead Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology

Target Recruit Count: 220

Registration Number: NCT05271162

Locations: 🇵🇱
Institute of Hematology and Transfusion Medicine, Warsaw, Poland
🇵🇱
National Institute of Oncology, Warsaw, Poland

Planned Non-operative Management for Rectal Cancer

Phase 2

Conditions: Rectal Cancer

Interventions: Radiation: Radiotherapy boost
Drug: Additional consolidation chemotherapy

First Posted Date: 2022-02-15

Last Posted Date: 2022-02-15

Lead Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology

Target Recruit Count: 23

Registration Number: NCT05241574

Locations: 🇵🇱
M. Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland

Atherosclerosis in Chemotherapy-related Cardiotoxicity

Active, not recruiting

Conditions: Cardiotoxicity
Atherosclerosis

First Posted Date: 2021-11-11

Last Posted Date: 2024-11-27

Lead Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology

Target Recruit Count: 80

Registration Number: NCT05118178

Locations: 🇵🇱
National Institute of Oncology, Warsaw, Poland

Analysis of Prevalence and Risk Factors Associated With Gastroesophageal Reflux Disease and Esophagitis After Peroral Endoscopic Myotomy

Recruiting

Conditions: GERD
Achalasia

First Posted Date: 2021-10-18

Last Posted Date: 2021-10-18

Lead Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology

Target Recruit Count: 100

Registration Number: NCT05080634

Locations: 🇵🇱
Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland

Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 OVERALL

Phase 2

Not yet recruiting

Conditions: CD20-positive Acute Lymphoblastic Leukemia

Interventions: Drug: Rituximab
Drug: Obinutuzumab

First Posted Date: 2021-06-10

Last Posted Date: 2021-06-10

Lead Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology

Target Recruit Count: 124

Registration Number: NCT04920968

Locations: 🇵🇱
Klinika Hematologii Collegium Medicum Uniwersytetu Jagiellońskiego, Kraków, Poland
🇵🇱
Oddział Hematologiczny Z Oddziałem Nowotworów Krwi Dolnośląskie Centrum Transplantacji Komórkowych Z Krajowym Bankiem Dawców Szpiku, Wrocław, Poland
🇵🇱
Klinika Hematologii z Pododziałem Chorób Naczyń Uniwersyteckiego, Białystok, Poland

and more 16 locations

Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment

Phase 2

Not yet recruiting

Conditions: Nasopharyngeal Cancer

Interventions: Drug: Opdivo

First Posted Date: 2021-05-06

Last Posted Date: 2021-06-23

Lead Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology

Target Recruit Count: 32

Registration Number: NCT04875611

Locations: 🇵🇱
Klinika Hematologii z Pododziałem Chorób Naczyń Uniwersyteckiego Szpitala Klinicznego w Białymstoku, Białystok, Poland
🇵🇱
Klinika Hematologii i Transplantologii Gdańskiego Uniwersytetu Medycznego, Gdańsk, Poland
🇵🇱
Klinika Transplantacji Szpiku i Onkohematologii Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy, Oddział w Gliwicach, Gliwice, Poland

and more 1 locations

Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With AML (Acute Myeloid Leukemia) and Myelodysplastic Syndromes

Phase 2

Not yet recruiting

Conditions: Acute Myeloid Leukemia Myelodysplastic Syndromes

Interventions: Drug: Cladribine

First Posted Date: 2021-04-27

Last Posted Date: 2021-05-06

Lead Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology

Target Recruit Count: 40

Registration Number: NCT04861207

Locations: 🇵🇱
Klinika Transplantacji Szpiku i Onkohematologii Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy, Oddział w Gliwicach, Gliwice, Poland

Stereotactic Management of Arrhythmia - Radiosurgery in Treatment of Ventricular Tachycardia

Not Applicable

Completed

Conditions: Ventricular Tachycardia

Interventions: Radiation: Cardiac Radiosurgery

First Posted Date: 2020-11-24

Last Posted Date: 2023-03-15

Lead Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology

Target Recruit Count: 11

Registration Number: NCT04642963

Locations: 🇵🇱
Upper Silesian Medical Center Professor Leszek Giec of the Medical University of Silesia in Katowice, Katowice, Poland
🇵🇱
Maria Sklodowska-Curie National Research Institute of Oncology (MSCNRIO), Gliwice branch, Gliwice, Śląskie, Poland

Comparison of Zenker's Diverticulum Treatment Using Peroral Endoscopic Myotomy and Flexible Endoscopy Septotomy.

Not Applicable

Conditions: Diverticulum, Esophago-Pharyngeal
Diverticulum, Esophageal
Dysphagia
Zenker Diverticulum
Gastrointestinal Disease

Interventions: Procedure: Peroral endoscopic myotomy
Procedure: Flexible endoscopic septotomy

First Posted Date: 2020-08-14

Last Posted Date: 2020-08-14

Lead Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology

Target Recruit Count: 165

Registration Number: NCT04514042

Locations: 🇵🇱
The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy